Testing effectiveness (Phase 2)Study completedNCT03117309
What this trial is testing
Study of Front Line Therapy With Nivolumab and Salvage Nivolumab + Ipilimumab in Patients With Advanced Renal Cell Carcinoma
Who this might be right for
Advanced Renal Cell Carcinoma
Michael B. Atkins, MD 164